Immunotherapy Toxicities.

This article summarizes toxicities, potential mechanisms of action, management strategies, and other clinical considerations. Unique mechanisms of action and immune-related toxicities of other FDA-approved classes of immunotherapy are reviewed. PMID: 31079795 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31079795?dopt=Abstract

Source: The Surgical Clinics of North America - May 14, 2019 Category: Surgery Authors: Sanchez K, Page DB, Urba W Tags: Surg Oncol Clin N Am Source Type: research

More News: Immunotherapy | Surgery | Toxicology